Article
Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.
Pediatric clinics of North America - 1 Feb 2015
Tarlock Katherine, Meshinchi Soheil
Abstract excerpt
Acute myeloid leukemia (AML) is a molecularly heterogeneous disease and age-associated molecular alterations result in younger children harboring a distinct signature from older children and adolescents. Pediatric AML has a genetic and epigenetic profile with significant differences compared to adult AML. Somatic and epigenetic alterations contribute to myeloid leukemogenesis and can evolve from diagnosis to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
